Cardiac Emergency References

Feb. 6, 2006 - Natural Products Industry INSIDER
"Cardiac Emergency" References

1. Trichopoulou A et al. Mediterranean diet and survival among patientswith coronary heart disease in Greece. Arch Intern Med. 165, 8:929-35, 2005. http://archinte.ama-assn.org

2. Bazzano LA et al. "Dietary fiber intake and reduced risk of coronaryheart disease in U.S. men and women: the National Health and NutritionExamination Survey I Epidemiologic Follow-Up Study." Arch Intern Med. 163,16:1897-904, 2003. http://archinte.ama-assn.org

3. Mozaffarian D et al. "Cereal, fruit and vegetable fiber intake andthe risk of cardiovascular disease in elderly individuals." JAMA. 289,13:1659-66, 2003. www.jama.com

4. Pereira MA et al. "Dietary fiber and risk of coronary heart disease:a pooled analysis of cohort studies." Arch Intern Med. 164, 4:370-6, 2004. http://archinte.ama-assn.org

5. Hu FB et al. Dietary protein and risk of ischemic heart disease inwomen. AJCN. 70, 2:221-7, 1999. www.ajcn.org

6. Willmot M et al. A systematic review of nitric oxide donors andL-arginine in experimental stroke; effects on infarct size and cerebral bloodflow. Nitric Oxide. 12, 3:141-9, 2005. http://www.sciencedirect.com/science/journal/10898603

7. Noguchi T et al. "Nutritional prevention on hypertension, cerebralhemodynamics and thrombosis in stroke-prone spontaneously hypertensiverats." Cell Mol Neurobiol. 24, 5:599-638, 2004.

8. Regensteiner JG et al. "Oral L-arginine and vitamins E and C improveendothelial function in women with type 2 diabetes." Vasc Med. 8, 3:169-75,2003.

9. Sakai K et al. Overexpression of eNOS in brain stem reduces enhancedsympathetic drive in mice with myocardial infarction. Am J Physiol Heart CircPhysiol. 289, 5:H2159-66, 2005. http://ajpheart.physiology.org

10. Rakhmatullina FF et al. The course of experimental myocardialinfarction under conditions of Suppressed and enhanced NO synthesis. Bull ExpBiol Med. 139, 4:384-7, 2005.

11. Bednarz B et al. Efficacy and safety of oral l-arginine in acutemyocardial infarction. Results of the multicenter, randomized, double-blind,placebo-controlled ARAMI pilot trial. Kardiol Pol. 62, 5:421-7, 2005.

12. Schulman SP et al. L-arginine therapy in acute myocardial infarction:the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI)randomized clinical trial. JAMA. 295, 1:58-64, 2006. www.jama.com

13. Herrera MD et al. "Endothelium-dependent vasorelaxation induced byL-carnitine in isolated aorta from normotensive and hypertensive rats." JPharm Pharmacol. 54, 10:1423-7, 2002. http://jpp.pharmpress.com/content/html/index.htm

14. Sethi R et al. Improvement of cardiac function and beta-adrenergicsignal transduction by propionyl L-carnitine in congestive heart failure due tomyocardial infarction. Coron Artery Dis. 15, 1:65-71, 2004. http://www.coronary-artery.com

15. Cui J et al. "Effects of L-carnitine and its derivatives onpostischemic cardiac function, ventricular fibrillation and necrotic andapoptotic cardiomyocyte death in isolated rat hearts." Mol Cell Biochem.254, 1-2:227-34, 2003. www.wkap.nl

16. Pauley DF and Pepine CJ. The role of carnitine in myocardialdysfunction. Am J Kidney Dis. 41, 4 Suppl 4:S35-43, 2003. www.ajkd.org

17. Wilcken DE. "Overview of inherited metabolic disorders causingcardiovascular disease." J Inherit Metab Dis. 26, 2-3:245-57, 2003.

18. Nettleton JA and Katz R. n-3 long-cahin polyunsaturated fatty acids intype 2 diabetes: a review. J Amer Diet Assoc. 105, 3:428-40, 2005. www.adajournal.org

19. Mozaffarian D et al. "Fish intake and risk of incident atrialfibrillation." Circulation. 110:368-73, 2004. http://circ.ahajournals.org/

20. Iso H. "Intake of fish and omega-3 fatty acids and risk of stroke inwomen." JAMA. 285, 3:304-12, 2001. www.jama.com

21. [No authors listed.] "Dietary supplementation with n-3polyunsaturated fatty acids and vitamin E after myocardial infarction: resultsof the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio dellaSopravvivenza nell-Infarto miocardio." Lancet. 354, 9177:447-55, 1999. www.thelancet.com

22. Raitt MH et al. Fish oil supplementation and risk of ventriculartachycardia and ventricular fibrillation in patients with implantabledefibrillators: a randomized controlled trial. JAMA. 293, 23:2884-91, 2005. www.jama.com

23. Leaf A et al. Prevention of fatal arrhythmias in high-risk subjects byfish oil n-3 fatty acid intake. Circulation. 112, 18:2762-8, 2005. http://circ.ahajournals.org

24. Geelen A et al. Effects of n-3 fatty acids from fish on prematureventricular complexes and heart rate in humans. Am J Clin Nutr. 81, 2:416-20,2005. www.ajcn.org

25. Holguin F et al. Cardiac autonomic changes associated with fish oil vssoy oil supplementation in the elderly. Chest. 127, 4:1102-7, 2005. www.chestjournal.org

26. Esterhuyse AJ et al. Dietary red palm oil improves reperfusion cardiacfunction in the isolated perfused rat heart of animals fed a high cholesteroldiet. Prostaglandins Leukot Essent Fatty Acids. 72, 3:153-61, 2005. http://www.sciencedirect.com/science/journal/09523278

27. Toit ED et al. Dietary red palm oil supplementation protects againstthe consequences of global ischemia in the isolated perfused rat heart. AsiaPac J Clin Nutr. 14, 4:340-7, 2005.

28. Dauchet L et al. Fruit and vegetable consumption and risk of stroke: ameta-analysis of cohort studies. Neurology. 65, 8:1193-7, 2005. www.neurology.org

29. Hak AE et al. "Prospective study of plasma carotenoids andtocopherols in relation to risk of ischemic stroke." Stroke. 35, 7:1584-8,2004. http://stroke.ahajournals.org/

30. Chang CY et al. Plasma levels of lipophilic antioxidant vitamins inacute ischemic stroke patients: correlation to inflammation markers andneurological deficits. Nutrition. 21, 10:987-93, 2005. http://www.sciencedirect.com/science/journal/08999007

31. Kabagambe EK et al. Some dietary and adipose tissue carotenoids areassociated with the risk of nonfatal acute myocardial infarction in Costa Rica.J Nutr. 135, 7:1763-9, 2005. www.nutrition.org

32. Yamamoto J et al. Tomatoes have natural anti-thrombotic effects. BrJ Nutr. 90, 6:1031-38, 2003. www.nutritionsociety.org.uk/bjn/

33. Rissanen TH et al. "Low serum lycopene concentration is associatedwith an excess incidence of acute coronary events and stroke: the KuopioIschaemic Heart Disease Risk Factor Study." Br J Nutr. 85, 6:749-54, 2001. www.cabi-publishing.org/journals/bjn

34. Arab L and Steck S. Lycopene and cardiovascular desease. Amer JClin Nutr. 71, 6:1691S-95S, 2000. www.ajcn.org

35. Hussein G et al. Antihypertensive and neuroprotective effects ofastaxanthin in experimental animals. Biol Pharm Bull. 28, 1:47-52, 2005. www.jstage.jst.go.jp/browse/bpb

36. Gross GJ, Lockwood SF. "Cardioprotection and myocardial salvage by adisodium disuccinate astaxanthin derivative (Cardax)." Life Sci.75:215-24, 2004. www.sciencedirect.com/science/journal/00243205

37. Naito Y et al. Astaxanthin limits exercise-induced skeletal andcardiac muscle damage in mice. Antioxid Redox Signal. 5, 1:139-44, 2003. www.liebertonline.com

38. Lee IM et al. Vitamin E in the primary prevention of cardiovasculardisease and cancer: the Women's Health Study: a randomized controlled trial.JAMA. 294, 1:56-65, 2005. www.jama.com

39. Lonn E et al. Effects of long-term vitamin E supplementation oncardiovascular events and cancer: a randomized controlled trial. JAMA. 293,11:1338-47, 2005. www.jama.com

40. Khanna S et al. Neuroprotective properties of the natural vitamin Ealpha-tocotrienol. Stroke. 36, 10:2258-64, 2005. http://stroke.ahajournals.org

41. Krantzopoulos P et al. The possible role of oxidative stress in heartfailure and the potential of antioxidant intervention. Med Sci Monit. 9,6:RA120-5, 2003. www.medscimonit.com

42. Ullegaddi R et al. Antioxidant supplementation enhances antioxidantcapacity and mitigates oxidative damage following acute ischaemic stroke. EurJ Clin Nutr. 59, 12:1367-73, 2005. www.nature.com/ecjn/

43. Dusinska M et al. Nutritional supplementation with antioxidantsdecreases chromosomal damage in humans. Mutagenesis. 18, 4:371-6, 2003. http://mutage.oupjournals.org

44. Wei WQ et al. "Prospective study of serum selenium concentrationsand esophageal and gastric cardia cancer, heart disease, stroke and totaldeath." Am J Clin Nutr. 79, 1:80-5, 2004. www.ajcn.org

45. Gums JG. "Magnesium in cardiovascular and other disorders." AmJ Health Syst Pharm. 61, 15:1569-76, 2004.

46. Umesawa M et al. Dietary intake of calcium in relation to mortalityfrom cardiovascular disease: the JACC Study. Stroke. 37, 1:20-6, 2006. http://stroke.ahajournals.org/

47. Gualler E et al. Low toenail chromium concentration and increased riskof nonfatal myocardial infarction. Am J Epidemiol. 162, 2:157-64., 2005. http://aje.oupjournals.org

48. Li Y et al. Marginal dietary copper restriction induces cardiomyopathyin rats. J Nutr. 135, 9:2130-6, 2005. www.nutrition.org

49. Holmquist C et al. Multivitamin supplements are inversely associatedwith risk of myocardial infarction in men and women--Stockholm HeartEpidemiology Program (SHEEP). J Nutr. 133, 8:2650-4, 2003. www.nutrition.org

50. Lee BJ et al. "Homocysteine and risk of coronary artery disease:Folate is the important determinant of plasma homocysteine concentration."Nutrition. 19, 7-8:577-83, 2003. www.elsevier.com/locate/nut

51. Hernandez-Diaz S et al. "Dietary folate and the risk of nonfatalmyocardial infarction." Epidemiology. 13, 6:700-6, 2002.

52. Spence JD et al. Vitamin Intervention For Stroke Prevention trial: anefficacy analysis. Stroke. 36, 11:2404-9, 2005. http://stroke.ahajournals.org/

53. Ullegaddi R, Powers HJ, Gariballa SE. "B-group vitaminsupplementation mitigates oxidative damage after acute ischaemic stroke."Clin Sci (Lond). 107, 5:477-84, 2004.

54. Schnyder G et al. "Effect of homocysteine-lowering therapy withfolic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneouscoronary intervention: the Swiss Heart study: a randomized controlledtrial." JAMA. 288, 8:973-9, 2002. www.jama.com

55. Wang Y et al. Dietary supplementation with blueberries, spinach, orspirulina reduces ischemic brain damage. Exp Neurol. 193, 1:75-84, 2005. http://www.sciencedirect.com/science/journal/00144886

56. Siddiqui IA et al. "Antioxidants of the beverage tea in promotion ofhuman health." Antioxid Redox Signal. 6, 3:571-82, 2004. www.liebertpub.com/publication.aspx?pub_id=4

57. Arts IC et al. Catechin intake might explain the inverse relationbetween tea consumption and ischemic heart disease: the Zutphen Elderly Study.Am J Clin Nutr. 74, 2:227-32, 2001. www.ajcn.org

58. Geleijnse JM et al. Inverse association of tea and flavonoid intakeswith incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 75,5:880-6, 2002. www.ajcn.org

59. Garcia-Estrada J et al. "An alpha-lipoic acid-vitamin E mixturereduces post-embolism lipid peroxidation, cerebral infarction and neurologicaldeficit in rats." Neurosci Res. 47, 2:219-24, 2003.

60. Kwong LK et al. "Effects of coenzyme Q10 administration on itstissue concentrations, mitochondrial oxidant generation and oxidative stress inthe rat." Free Rad Biol Med. 33, 5:627-38, 2002. www.elsevier.com/locate/freeradbiomed

61. Tran MT et al. "Role of coenzyme Q10 in chronic heart failure,angina and hypertension." Pharmacotherapy. 21, 7:797-806, 2001. www.iospress.nl/site/html/02770008.html

62. Weant KA and Smith KM. The role of coenzyme Q10 in heart failure.Ann Pharmacother. 39, 9:1522-6, 2005. www.theannals.com

63. Salles JE et al. Myocardial dysfunction in mitochondrial diabetestreated with Coenzyme Q10. Diabetes Res Clin Pract. Oct 24, 2005 [Epub aheadof print.] www.sciencedirect.com/science/journal/01688227

64. Sarter B. "Coenzyme Q10 and cardiovascular disease: a review."J Cardiovasc Nurs. 16, 4:9-20, 2002.

65. Carter O et al. D-Ribose supplementation improves peak exercisecapacity and ventilatory efficiency in heart failure patients. J Amer CollCardiol. 45, 3SA:185, 2005. www.acc.org

66. Sharma R et al. D-Ribose improves Doppler TEI myocardial performanceindex and maximal exercise capacity in stage C heart failure. JMCC. 38,5:835, 2005.

67. Perkowski D et al. Pre-surgical loading of oral D-ribose improvescardiac index in patients undergoing off pump coronary arteryrevascularization. FASEB j. 19, 4:A695, 2005.

68. Degenring FH et al. "A randomized double blind placebo controlledclinical trial of a standardized extract of fresh Crataegus berries(Crataegisan) in the treatment of patients with congestive heart failure NYHAII." Phytomedicine. 10, 5:363-9, 2003. www.urbanfischer.de/journals/frame_template.htm?/journals/phytomed/phytmed.htm

69. Habs M. "Prospective, comparative cohort studies and theircontribution to the benefit assessments of therapeutic options: heart failuretreatment with and without Hawthorn special extract WS 1442." ForschKomplementarmed Klass Naturheilkd. 11 Suppl. 1:36-9, 2004.

70. Pittler MH, Schmidt K, Ernst E. "Hawthorn extract for treatingchronic heart failure: meta-analysis of randomized trials." Am J Med. 114,8:665-74, 2003.

71. Mahady GB. "Ginkgo biloba for the prevention and treatment ofcardiovascular disease: a review of the literature." J Cardiovasc Nurs. 16,4:21-32, 2002.

72. Rioufol G et al. Ginkgo biloba extract EGb 761 attenuates myocardialstunning in the pig heart. Basic Res Cardiol. 98, 1:59-68, 2003. http://www.springerlink.com/link.asp?id=401550

73. Sasaki Y et al. Effects of Ginkgo biloba extract (EGb 761) on cerebralthrombosis and blood pressure in stroke-prone spontaneously hypertensive rats.Clin Exp Pharmacol Physiol. 29, 11:963-7, 2002. http://www.blackwell-synergy.com/loi/cep

74. Zeng X et al. Ginkgo biloba for acute ischaemic stroke. CochraneDatabase Syst Rev. 4:CD003691, 2005.http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME

75. Rohdewald P. "A review of the French maritime pine bark extract(Pycnogenol), a herbal medication with a diverse clinical pharmacology."Int J Clin Pharmacol Ther. 40, 4:158-68, 2002.

76. Liu X et al. Pycnogenol, French maritime pine bark extract, improvesendothelial function of hypertensive patients. Life Sci. 74, 7:855-62, 2004. www.sciencedirect.com/science/journal/00243205

77. Belcaro G et al. Venous ulcers: microcirculatory improvement andfaster healing with local use of pycnogenol. Angiology. 56, 6:699-705, 2005.

78. Fu XC et al. Vasodilatation produced by orientin and its mechanismstudy. Biol Pharm Bull. 28, 1:37-41, 2005. www.jstage.jst.go.jp/browse/bpb